EFFECT OF INTRAVENOUS POLYUNSATURATED PHOSPHATIDYLCHOLINE INFUSION ON INSULIN-RECEPTOR PROCESSING AND LIPID-COMPOSITION OF ERYTHROCYTES IN PATIENTS WITH LIVER-CIRRHOSIS

被引:10
作者
CANTAFORA, A
MASELLA, R
ANGELICO, M
GANDIN, C
BLOUNT, RJ
PETERSON, SW
机构
[1] ARKANSAS COLL,BATESVILLE,AR
[2] IST SUPER SANITA,CATTEDRA GASTROENTEROL 2,I-00161 ROME,ITALY
关键词
CHOLESTEROL; CIRRHOSIS; ERYTHROCYTE; INSULIN RECEPTOR; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID;
D O I
10.1111/j.1365-2362.1992.tb01446.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study was to determine whether insulin receptor processing capabilities of human erythrocytes could be improved by changing the cell membrane lipid composition using an intravenous infusion of polyunsaturated phosphatidylcholine. Thirteen cirrhotics were submitted to the i.v. infusion of phosphatidylcholine (2 g day-1 for 3 days). Both erythrocyte lipid composition and insulin receptor processing ability were examined at the beginning of the study and at 0, 3 and 11 days after the end of the treatment. This treatment decreased the erythrocyte cholesterol to phospholipid molar ratio and increased the proportion of polyunsaturated fatty acids (mainly linoleic acid) immediately after the end of the treatment. The proportion of arachidonic acid increased immediately in the phosphatidylserine class and, a few days later, also in phosphatidylethanolamine. The phospholipid class distribution did not show any relevant modification in the course of the study. Surface insulin receptors, which generally were upregulated in the untreated subject (-7.1 +/- 20.4%), showed an improvement in down regulation capabilities that appeared to be well correlated with the changes in lipid composition of cell membranes induced by i.v. infusion of polyunsaturated phosphatidylcholine. The confirmation of these findings also in target cells for insulin may open new perspectives in the treatment of diabetes mellitus.
引用
收藏
页码:777 / 782
页数:6
相关论文
共 29 条
[1]   ABNORMALITIES IN ERYTHROCYTE-MEMBRANE PHOSPHOLIPIDS IN PATIENTS WITH LIVER-CIRRHOSIS [J].
ALVARO, D ;
ANGELICO, M ;
ATTILI, AF ;
DESANTIS, A ;
PIECHE, U ;
CAPOCACCIA, L .
BIOCHEMICAL MEDICINE, 1982, 28 (02) :157-164
[2]  
ANGELICO F, 1980, NUTR METAB, V24, P148
[3]  
BARTLETT GR, 1959, J BIOL CHEM, V234, P466
[4]  
BRAVO E, 1989, Giornale Italiano di Chimica Clinica, V14, P141
[5]   ANALYSIS OF LIPOPROTEINS, BILE-ACIDS, AND RED-CELL MEMBRANES ASSOCIATED WITH TARGET CELLS AND SPUR CELLS IN PATIENTS WITH LIVER-DISEASE [J].
COOPER, RA ;
GREENBERG, MS ;
DILOYPUR.M ;
LANDO, P .
JOURNAL OF CLINICAL INVESTIGATION, 1972, 51 (12) :3182-+
[6]  
DUHAMEL G, 1983, J LIPID RES, V24, P1612
[7]  
DUSTIN ML, 1984, J BIOL CHEM, V259, P3660
[8]  
FRIEDMAN M, 1957, P SOC EXP BIOL MED, V95, P586
[9]   INSULIN BINDING AND DEGRADATION BY HUMAN-ERYTHROCYTES AT PHYSIOLOGICAL TEMPERATURE [J].
GAMBHIR, KK ;
NERURKAR, SG ;
DAS, PD ;
ARCHER, JA ;
HENRY, WL .
ENDOCRINOLOGY, 1981, 109 (05) :1787-1789
[10]   CHARACTERISTICS OF HUMAN ERYTHROCYTE INSULIN RECEPTORS [J].
GAMBHIR, KK ;
ARCHER, JA ;
BRADLEY, CJ .
DIABETES, 1978, 27 (07) :701-708